Phase II trial of vorinostat, a histone deacetylase inhibitor to restore the hormone sensitivity to the anti-estrogen tamoxifen in patients with advanced breast cancer having failed prior aromatase inhibitor therapy

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 3501-3501 ◽  
Author(s):  
P. N. Munster ◽  
M. Lacevic ◽  
M. Schmitt ◽  
E. Bicaku ◽  
D. Marchion ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Aromatase Inhibitor ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Aromatase Inhibitor Therapy ◽  
Hormone Sensitivity ◽  
Deacetylase Inhibitor

scholarly journals Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1281-1288 ◽  
Author(s):  
Missak Haigentz ◽  
Mimi Kim ◽  
Catherine Sarta ◽  
Juan Lin ◽  
Roger S. Keresztes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Neck Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Deacetylase Inhibitor

Treatment of advanced breast cancer with the aromatase inhibitor 4-hydroxyandrostenedione: a phase II trial

The Breast ◽  
1994 ◽  
Vol 3 (1) ◽  
pp. 27-30
Author(s):  
A. Bowman ◽  
J.F. Smyth ◽  
M.E. Stewart ◽  
A. Rodger ◽  
M. Dowsett ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Aromatase Inhibitor ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast
Sign in / Sign up

Export Citation Format

Share Document